Key Takeaways
- Keto can help some adults lose weight over several months.
- Blood sugar often drops on keto, especially in type 2 diabetes.
- Seizure control remains the best proven medical use of keto.
- LDL cholesterol may rise, so follow up and monitoring are wise.
- Long term success depends on food quality, support, and consistency.
What Keto Does
Core Plan
A ketogenic diet cuts carbohydrate intake very low and raises fat intake enough to shift the body toward ketone production. Ketones are small fuel molecules made by the liver when glucose, a blood sugar, becomes scarce (Dhillon and Gupta, 2023).
Most versions keep daily carbs low enough to maintain ketosis, which is the state where ketones rise and become a steady fuel source. Protein usually stays moderate, while foods rich in starch and sugar are kept small or removed.
Ketosis Basics
Ketosis does not happen by magic, and it does not start at the same pace for everyone. Sleep, exercise, total calories, protein intake, and prior carb intake can all change how fast someone reaches this state. The basic shift is well known in human biology. When stored carbohydrate runs low, the body increases fat use and the liver makes ketone bodies that can fuel many tissues, including the brain (Dhillon and Gupta, 2023).
Weight Loss Findings
Appetite & Intake
Many people feel less hungry on keto, which may lower total food intake without strict calorie counting. Higher protein intake, slower stomach emptying, and ketones themselves may all help with satiety, which is the feeling of fullness.
That effect can be useful during the first months of weight loss, especially for adults who do better with simple food rules than with portion tracking. Several trials and reviews found greater short to medium term weight loss on very low carbohydrate diets than on low fat diets, though the gap is often modest (Bueno et al., 2013; Bazzano et al., 2014).
Longer Term Results
The best summary of longer follow up still points to a mixed picture. A 2013 meta analysis found greater long term reductions in body weight and some heart risk markers with very low carbohydrate ketogenic diets than with low fat diets, but the size of the average benefit was not huge (Bueno et al., 2013).
A later review of low fat diet trials reached a related point from the other side. Low fat plans did not produce greater long term weight loss than higher fat plans when compared head to head (Tobias et al., 2015).
Adherence shapes results more than diet labels do. People tend to do well when the plan feels clear, meals are satisfying, and social eating stays manageable. People tend to struggle when the diet feels rigid, costly, or hard to sustain outside the home.
Blood Sugar Effects
Diabetes & Prediabetes
Blood sugar often improves on keto, especially over the short term in adults with prediabetes or type 2 diabetes. Fewer carbs usually means smaller rises in blood sugar after meals, and some studies also report lower fasting glucose and lower HbA1c, which is a blood test that shows average blood sugar over about three months (Parry-Strong et al., 2022; Westman et al., 2008).
An umbrella review of randomized trial meta analyses found beneficial effects on several cardiometabolic outcomes, including body weight and blood sugar related measures. The same review also found that LDL cholesterol, often called bad cholesterol, rose by a clinically meaningful amount in some studies (Patikorn et al., 2023).
How Keto Compared
Keto does not always beat every other solid eating plan. In a randomized crossover trial, a well formulated ketogenic diet and a Mediterranean style diet both improved HbA1c in adults with prediabetes or type 2 diabetes, with no major difference between them for that main outcome (Gardner et al., 2022).
That finding helps set fair expectations. Keto can improve blood sugar, yet it is one option among several that may work when the plan is built from real food and followed well. The best fit often depends on food preferences, cooking habits, budget, and whether the person can maintain the diet for months rather than days.
Lipids & Caution
Blood fats can move in different directions on keto. Triglycerides often fall and HDL cholesterol often rises, which many clinicians view as favorable. LDL cholesterol can also rise, sometimes sharply, and that deserves follow up rather than wishful thinking (Patikorn et al., 2023; Li and Yuan, 2022).
Food choice likely affects that response. Diets built around fish, eggs, unsweetened dairy, olive oil, nuts, seeds, avocado, and nonstarchy vegetables may produce a different lipid response than diets heavy in processed meats, butter coffee, and low carb snack foods. The label keto alone does not tell you much about diet quality.
Seizure Control
Strongest Use
The clearest clinical benefit of ketogenic therapy is seizure reduction in drug resistant epilepsy, especially in children. Reviews of randomized trials found that ketogenic diets and modified Atkins approaches improved seizure outcomes compared with usual care or less intensive diet plans (Sourbron et al., 2020; Mutarelli et al., 2023). This use has a long history in neurology, and it is still the best supported reason to use the diet as a medical treatment. Families who try it for epilepsy usually do so with close medical and dietitian support because the diet can affect growth, stomach comfort, nutrient intake, and medication needs.
Brain Health Hopes
Claims about keto and brain health beyond epilepsy get far more attention than firm proof. Research on Alzheimer disease, Parkinson disease, mood, and thinking remains early, limited, or mixed. Some reviews describe promise, though they also note the need for better trials with longer follow up (Włodarek, 2019; Ludwig, 2020).
Mood and thinking data do not support broad claims of mental sharpness for everyone. In one long term trial, both low carbohydrate and low fat diets improved mood during weight loss, but the low fat group showed a more favorable result on some mood and cognitive measures over one year (Brinkworth et al., 2009).
Who May Benefit
Better Candidates
Adults who want a simple way to lower carb intake, reduce hunger, or improve blood sugar may find keto useful, at least for a defined period. People with drug resistant epilepsy may also benefit when the diet is used as part of clinical care. Those groups still need a clear plan for meals, fluids, electrolytes, fiber tolerance, and follow up labs. Good support improves the odds of staying consistent and spotting problems early.
Limits To Know
Keto can be hard to sustain, and side effects are common during the first week or two. Constipation, headache, fatigue, bad breath, and exercise dips are often reported early. Social eating can also become hard when most shared foods are built around bread, rice, sweets, or alcohol.
Some people should not try keto without direct medical guidance, especially those who use glucose lowering drugs, have kidney disease, are pregnant, or have a history of eating disorders. A strong diet is one a person can follow safely and steadily, not one that looks perfect on paper.
Before changing your diet, supplements, or health routine, talk with a licensed healthcare professional. For any health concerns or questions about a medical condition, get guidance from a physician or another appropriately trained clinician.
FAQs
What are the main ketogenic diet benefits?
The best studied benefits are weight loss over the short to medium term, better blood sugar control for some adults, and seizure reduction in drug resistant epilepsy.
Is keto better than a low fat diet?
Keto often does a bit better for short term weight loss and blood sugar, but long term results depend a lot on adherence and food quality.
Can keto help with type 2 diabetes?
It can help some adults lower blood sugar and HbA1c, though it may not outperform every other strong eating plan.
Is keto safe for long term use?
Some people use it for long periods, but safety depends on medical history, food quality, and regular follow up, especially when LDL rises.
What foods support ketosis?
Meals often center on eggs, fish, meat, full fat dairy, oils, nuts, seeds, avocado, and low starch vegetables while sugars and grains stay very low.
Research
Dhillon, K.K. and Gupta, S. (2023) Biochemistry, Ketogenesis. Treasure Island, FL: StatPearls Publishing. Available at: https://www.ncbi.nlm.nih.gov/books/NBK493179/ (Accessed: 7 April 2026).
Bueno, N.B., de Melo, I.S.V., de Oliveira, S.L. and da Rocha Ataide, T. (2013) ‘Very-low-carbohydrate ketogenic diet v. low-fat diet for long-term weight loss: a meta-analysis of randomised controlled trials’, British Journal of Nutrition, 110(7), pp. 1178–1187. Available at: https://pubmed.ncbi.nlm.nih.gov/23651522/ (Accessed: 7 April 2026).
Bazzano, L.A., Hu, T., Reynolds, K., Yao, L., Bunol, C., Liu, Y., Chen, C.S., Klag, M.J., Whelton, P.K. and He, J. (2014) ‘Effects of low-carbohydrate and low-fat diets: a randomized trial’, Annals of Internal Medicine, 161(5), pp. 309–318. Available at: https://pubmed.ncbi.nlm.nih.gov/25178568/ (Accessed: 7 April 2026).
Tobias, D.K., Chen, M., Manson, J.E., Ludwig, D.S., Willett, W. and Hu, F.B. (2015) ‘Effect of low-fat diet interventions versus other diet interventions on long-term weight change in adults: a systematic review and meta-analysis’, The Lancet Diabetes & Endocrinology, 3(12), pp. 968–979. Available at: https://pubmed.ncbi.nlm.nih.gov/26527511/ (Accessed: 7 April 2026).
Parry-Strong, A., Krebs, J.D., Leikis, M., Phillips, A.R.J. and Stonehouse, W. (2022) ‘Very low carbohydrate ketogenic diets in type 2 diabetes: a systematic review and meta-analysis of randomized controlled trials’, Diabetes, Obesity and Metabolism, 24(12), pp. 2431–2442. Available at: https://pubmed.ncbi.nlm.nih.gov/36064937/ (Accessed: 7 April 2026).
Westman, E.C., Yancy, W.S. Jr, Mavropoulos, J.C., Marquart, M. and McDuffie, J.R. (2008) ‘The effect of a low-carbohydrate, ketogenic diet versus a low-glycemic index diet on glycemic control in type 2 diabetes mellitus’, Nutrition & Metabolism, 5, 36. Available at: https://pubmed.ncbi.nlm.nih.gov/19099589/ (Accessed: 7 April 2026).
Patikorn, C., Roubal, K., Veettil, S.K., Chandran, V., Pham, T., Lee, Y.Y., Giovannucci, E.L., Varady, K.A., Chaiyakunapruk, N. and Chantarat, T. (2023) ‘Effects of ketogenic diet on health outcomes: an umbrella review of meta-analyses of randomized clinical trials’, BMC Medicine, 21, 196. Available at: https://pubmed.ncbi.nlm.nih.gov/37231411/ (Accessed: 7 April 2026).
Gardner, C.D., Landry, M.J., Perelman, D., Petlura, C., Durand, L.R., Aronica, L., Crimarco, A., Hall, K.D., Santa Cruz, S., Newman, J.W., Ramakrishnan, R., Kanaya, A.M., Sanyoura, M. and Ali, M.R. (2022) ‘Effect of a ketogenic diet versus Mediterranean diet on glycated hemoglobin in individuals with prediabetes and type 2 diabetes mellitus: the interventional Keto-Med randomized crossover trial’, The American Journal of Clinical Nutrition, 116(3), pp. 640–652. Available at: https://pubmed.ncbi.nlm.nih.gov/35641199/ (Accessed: 7 April 2026).
Li, M. and Yuan, J. (2022) ‘Effects of very low-carbohydrate ketogenic diet on lipid metabolism in patients with type II diabetes mellitus: a meta-analysis’, Nutrición Hospitalaria, 39(4), pp. 916–923. Available at: https://pubmed.ncbi.nlm.nih.gov/35243868/ (Accessed: 7 April 2026).
Sourbron, J., Klinkenberg, S., van Kuijk, S.M.J. and Lagae, L. (2020) ‘Ketogenic diet for the treatment of pediatric epilepsy: review and meta-analysis’, Child’s Nervous System, 36(6), pp. 1099–1109. Available at: https://pubmed.ncbi.nlm.nih.gov/32173786/ (Accessed: 7 April 2026).
Mutarelli, A., Nogueira, A., Felix, N. and Lin, K. (2023) ‘Modified Atkins diet for drug-resistant epilepsy: a systematic review and meta-analysis of randomized controlled trials’, Seizure, 112, pp. 77–83. Available at: https://pubmed.ncbi.nlm.nih.gov/37769548/ (Accessed: 7 April 2026).
Włodarek, D. (2019) ‘Role of ketogenic diets in neurodegenerative diseases (Alzheimer’s disease and Parkinson’s disease)’, Nutrients, 11(1), 169. Available at: https://pmc.ncbi.nlm.nih.gov/articles/PMC6520897/ (Accessed: 7 April 2026).
Ludwig, D.S. (2020) ‘The ketogenic diet: evidence for optimism but high-quality research needed’, The Journal of Nutrition, 150(6), pp. 1354–1359. Available at: https://academic.oup.com/jn/article/150/6/1354/5802715 (Accessed: 7 April 2026).
Brinkworth, G.D., Buckley, J.D., Noakes, M., Clifton, P.M. and Wilson, C.J. (2009) ‘Long-term effects of a very low-carbohydrate diet and a low-fat diet on mood and cognitive function’, Archives of Internal Medicine, 169(20), pp. 1873–1880. Available at: https://pubmed.ncbi.nlm.nih.gov/19901139/ (Accessed: 7 April 2026).
Rafiullah, M., Al-Rifai, R.H., Al-Mawali, A. and Jaju, D. (2022) ‘Effect of a very low-carbohydrate ketogenic diet vs recommended diets in patients with type 2 diabetes: a meta-analysis’, Nutrition Reviews, 80(3), pp. 488–502.
Zhou, C., Shi, X., Wang, X., Sun, Y., Lu, C. and Wang, C. (2022) ‘Ketogenic diet benefits to weight loss, glycemic control, and lipid profiles in overweight patients with type 2 diabetes mellitus: a meta-analysis of randomized controlled trials’, International Journal of Environmental Research and Public Health, 19(16), 10429.
Zaki, H.A., Momen, A., El Bastawissy, A. and Zaki, N. (2022) ‘A comparative study evaluating the effectiveness between ketogenic and low-carbohydrate diets on glycemic and weight control in patients with type 2 diabetes mellitus: a systematic review and meta-analysis’, Cureus, 14(5), e25528.
Pizzo, F., Vetri, L., Falsaperla, R., Pavone, P. and Ruggieri, M. (2022) ‘Ketogenic diet in pediatric seizures: a randomized controlled trial review and meta-analysis’, Expert Review of Neurotherapeutics, 22(2), pp. 169–177.
Choi, Y.J., Jeon, S.M. and Shin, S. (2020) ‘Impact of a ketogenic diet on metabolic parameters in patients with obesity or overweight and with or without type 2 diabetes: a meta-analysis of randomized controlled trials’, Nutrients, 12(7), 2005.
Yancy, W.S. Jr, Olsen, M.K., Guyton, J.R., Bakst, R.P. and Westman, E.C. (2004) ‘A low-carbohydrate, ketogenic diet versus a low-fat diet to treat obesity and hyperlipidemia: a randomized, controlled trial’, Annals of Internal Medicine, 140(10), pp. 769–777.
Volek, J.S., Sharman, M.J., Gómez, A.L., Judelson, D.A., Rubin, M.R., Watson, G., Sokmen, B., Silvestre, R., French, D.N. and Kraemer, W.J. (2004) ‘Comparison of energy-restricted very low-carbohydrate and low-fat diets on weight loss and body composition in overweight men and women’, Nutrition & Metabolism, 1(1), 13.
Samaha, F.F., Iqbal, N., Seshadri, P., Chicano, K.L., Daily, D.A., McGrory, J., Williams, T., Williams, M. and Gracely, E.J. (2003) ‘A low-carbohydrate as compared with a low-fat diet in severe obesity’, New England Journal of Medicine, 348(21), pp. 2074–2081.
Foster, G.D., Wyatt, H.R., Hill, J.O., McGuckin, B.G., Brill, C., Mohammed, B.S., Szapary, P.O., Rader, D.J., Edman, J.S. and Klein, S. (2003) ‘A randomized trial of a low-carbohydrate diet for obesity’, New England Journal of Medicine, 348(21), pp. 2082–2090.
Broom, G.M., Shaw, I.C. and Rucklidge, J.J. (2019) ‘The ketogenic diet as a potential treatment and prevention strategy for Alzheimer’s disease’, Nutrition, 60, pp. 118–121.
D’Anci, K.E., Watts, K.L., Kanarek, R.B. and Taylor, H.A. (2009) ‘Low-carbohydrate weight-loss diets: effects on cognition and mood’, Appetite, 52(1), pp. 96–103.
Guzel, O., Uysal, U. and Arslan, N. (2019) ‘Efficacy and tolerability of olive oil-based ketogenic diet in children with drug-resistant epilepsy: a single center experience from Turkey’, European Journal of Paediatric Neurology, 23(1), pp. 143–151.
Jagadish, S., Payne, E.T., Wong-Kisiel, L.C., Nickels, K.C., Eckert, S., Wirrell, E.C. and Bergqvist, A.G.C. (2019) ‘The ketogenic and modified Atkins diet therapy for children with refractory epilepsy of genetic etiology’, Pediatric Neurology, 94, pp. 32–37.
Kim, J.M. (2017) ‘Ketogenic diet: old treatment, new beginning’, Clinical Neurophysiology Practice, 2, pp. 161–162.
Zhu, H., Bi, D., Zhang, Y., Kong, C., Du, J., Wu, X., Wei, Q. and Qin, H. (2022) ‘Ketogenic diet for human diseases: the underlying mechanisms and potential for clinical implementations’, Signal Transduction and Targeted Therapy, 7(1), 11.
Luong, T.V., Wall, J.A. and Glass, C. (2022) ‘Ketogenic diet and cardiac substrate metabolism’, Nutrients, 14(7), 1467.
Grotto, D. and Zied, E. (2010) ‘The Standard American Diet and its relationship to the health status of Americans’, Nutrition in Clinical Practice, 25(6), pp. 603–612.
Hernández, F. (2021) ‘Glycolysis and gluconeogenesis: a teaching view’, Journal of Biological Chemistry, 296, 100016.
Krebs, H.A. (1965) ‘Gluconeogenesis’, Exposés Annuels de Biochimie Médicale, 26, pp. 13–30.
Rodell, A., Olsen, B.B., Okkels, N., Palle, A. and Linneberg, A. (2013) ‘Natural selection of mitochondria during somatic lifetime promotes healthy aging’, Frontiers in Neuroenergetics, 5, 7.
